[go: up one dir, main page]

ZA963826B - A method of treatment of mania and bipolar disorder - Google Patents

A method of treatment of mania and bipolar disorder

Info

Publication number
ZA963826B
ZA963826B ZA963826A ZA963826A ZA963826B ZA 963826 B ZA963826 B ZA 963826B ZA 963826 A ZA963826 A ZA 963826A ZA 963826 A ZA963826 A ZA 963826A ZA 963826 B ZA963826 B ZA 963826B
Authority
ZA
South Africa
Prior art keywords
treatment
mania
bipolar disorder
gabapentin
recurrent
Prior art date
Application number
ZA963826A
Other languages
English (en)
Inventor
Atul Chandra Pande
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA963826B publication Critical patent/ZA963826B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
ZA963826A 1995-05-15 1996-05-14 A method of treatment of mania and bipolar disorder ZA963826B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/440,570 US5510381A (en) 1995-05-15 1995-05-15 Method of treatment of mania and bipolar disorder

Publications (1)

Publication Number Publication Date
ZA963826B true ZA963826B (en) 1996-11-21

Family

ID=23749281

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963826A ZA963826B (en) 1995-05-15 1996-05-14 A method of treatment of mania and bipolar disorder

Country Status (19)

Country Link
US (1) US5510381A (cs)
EP (1) EP0825857B1 (cs)
JP (1) JPH11505244A (cs)
AT (1) ATE218857T1 (cs)
AU (1) AU702435B2 (cs)
CA (1) CA2215923C (cs)
CZ (1) CZ288072B6 (cs)
DE (1) DE69621799T2 (cs)
DK (1) DK0825857T3 (cs)
EE (1) EE03420B1 (cs)
ES (1) ES2177783T3 (cs)
GE (1) GEP20002014B (cs)
HU (1) HUP9802087A3 (cs)
NO (1) NO315967B1 (cs)
NZ (1) NZ307366A (cs)
PT (1) PT825857E (cs)
SK (1) SK281982B6 (cs)
WO (1) WO1996036328A1 (cs)
ZA (1) ZA963826B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
AU9318398A (en) 1997-10-07 1999-04-27 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
PL199794B1 (pl) 1997-10-27 2008-10-31 Warner Lambert Co Związki pośrednie do wytwarzania pochodnych cyklicznych aminokwasów
IL139298A0 (en) 1998-05-15 2001-11-25 Warner Lambert Co Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
CU23051A3 (es) * 1998-05-15 2005-06-24 Warner Lambert Co Composiciones solidas que contienen derivados de acido gamma-aminobutirico y procesos para prepararlas.
KR20010043831A (ko) 1998-05-26 2001-05-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 칼슘 채널의 알파2델타 서브유닛에 대한 친화력이 있는구조적으로 한정된 아미노산 화합물
BR9911887A (pt) 1998-07-09 2001-03-27 Warner Lambert Co Método para o tratamento da insÈnia
DK1121114T3 (da) * 1998-10-16 2007-04-10 Warner Lambert Co Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser
WO2000073300A1 (en) * 1999-06-02 2000-12-07 Warner-Lambert Company Amino heterocycles useful as pharmaceutical agents
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
KR100667721B1 (ko) * 2000-06-16 2007-01-15 테바 파마슈티컬 인더스트리즈 리미티드 제어 범위 내의 ph를 갖는 안정한 가바펜틴
ES2300332T3 (es) * 2000-06-26 2008-06-16 Warner-Lambert Company Llc Analogos de gabapentina para trastornos del sueño.
ITMI20012750A1 (it) 2001-12-21 2003-06-21 Procos Spa Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
EP2575798B1 (en) 2010-06-01 2017-08-09 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs
WO2015144825A1 (en) 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin
US11670410B1 (en) * 2022-04-13 2023-06-06 Green Sky Creations LLC Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
US4355044A (en) * 1980-12-19 1982-10-19 Bernardo Heller D-Phenylalanine treatment
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression

Also Published As

Publication number Publication date
DE69621799D1 (de) 2002-07-18
SK281982B6 (sk) 2001-09-11
NO315967B1 (no) 2003-11-24
EE03420B1 (et) 2001-06-15
AU702435B2 (en) 1999-02-18
NZ307366A (en) 1999-10-28
SK152897A3 (en) 1999-05-07
US5510381A (en) 1996-04-23
HUP9802087A3 (en) 1999-08-30
EE9700302A (et) 1998-06-15
NO975234D0 (no) 1997-11-14
CA2215923C (en) 2001-10-09
DK0825857T3 (da) 2002-09-30
NO975234L (no) 1997-11-14
DE69621799T2 (de) 2003-01-02
AU5668996A (en) 1996-11-29
EP0825857A1 (en) 1998-03-04
EP0825857B1 (en) 2002-06-12
HUP9802087A2 (hu) 1998-12-28
JPH11505244A (ja) 1999-05-18
PT825857E (pt) 2002-11-29
CZ355897A3 (cs) 1998-02-18
GEP20002014B (en) 2000-04-10
CZ288072B6 (cs) 2001-04-11
CA2215923A1 (en) 1996-11-21
ATE218857T1 (de) 2002-06-15
MX9707269A (es) 1997-11-29
ES2177783T3 (es) 2002-12-16
WO1996036328A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
ZA963826B (en) A method of treatment of mania and bipolar disorder
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
HUS1300046I1 (hu) Izobutil-gaba és származékai alkalmazása fájdalom kezelésére alkalmas gyógyszer elõállítására
CA2258895A1 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
ID28003A (id) Turunan-turunan adamantana
AU6256996A (en) Use of vitamin D4 derivatives for treating skin disorders
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
EP0347864A3 (en) Anti-atherogenic agents
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
WO1992018536A3 (en) Method for detecting an localizing tissues having neurokinine 1 receptors
WO1998022099A3 (en) New use of creatine
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
EP0946179A4 (en) METHOD OF TREATING AUTISM
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ZA963744B (en) Topical aciclovir preparation
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
ZA977004B (en) Therapeutic product and its use
YU40098A (sh) Upotreba olanzapina za dobijanje leka
SI0825857T1 (en) Use of gabapentin and its derivatives in the treatment of mania and bipolar disorder
IL128768A0 (en) Transdermal therapeutic system containing oestriol
MX9701294A (es) Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora.
JO1880B1 (en) Format 1 for multi-unit calibration discs